Using Automated Calls To Improve Compliance With Acute Coronary Syndrome Best Practice Guidelines

University of Ottawa Heart Institute

Status: Completed

Conditions: Medication Adherence; Acute Coronary Syndrome

Treatments: Other: Using IVR to maintain ACS patients on best practice guidelines

Study type: Interventional

Funder types: Other

Identifiers

NCT01151800

UOHI 2006-128

Details and patient eligibility

About

The purpose of this study is to determine whether interactive voice response (IVR) technology can be used to bring post discharge care for acute coronary syndrome (ACS) closer to best practice guidelines (BPGs).

The study hypothesis is that ACS patients who are contacted by IVR technology will be more likely to receive care as recommended in the BPGs than those followed by usual care.

Full description

Acute coronary syndrome (ACS) is a significant public-health problem in Canada and worldwide with 20,000 Canadians dying of myocardial infarction and 42,000 dying of coronary artery disease in 1999. Large clinical trials have provided evidence for the development of standardized best practice guidelines (BPG) and compliance with these guidelines have significantly improved survival. Despite the development and dissemination of BPG, their application in patients with ACS is suboptimal. This randomized control trial will use 2 groups: IVR and usual care. Patients in the IVR group will receive 5 automated calls at 1,3,6,9 and 12 months consisting of predetermined questions related to medication management, smoking cessation, diet, exercise and education as recommended by the ACC/AHA BPG for ACS. Responses are captured in a database allowing for interventions to maintain patients on BPG as needed.

Enrollment: 1,608 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients discharged from the UOHI with ACS (acute myocardial infarction, STEMI or NSTEMI)
• Patients who have a land line telephone service at home
• Patients who speak English or French

Exclusion criteria

• Patients discharged to a care facility or transferred to another health care institution

Trial design

1,608 participants in 2 patient groups

IVR group

Experimental group

Treatment:

Other: Using IVR to maintain ACS patients on best practice guidelines

Usual care

No Intervention group